Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Müllertz

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Biochemical Journal|November 1, 1974
Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrinS Müllertz
Scandinavian Journal of Haematology. Supplementum|January 1, 1979
The fibrinolytic systemS Müllertz
Seminars in Thrombosis and Hemostasis|January 1, 1984
Fibrinolysis: an overviewS Müllertz
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1972
Molecular forms of plasmin and protease inhibitors in human fibrinolytic post-mortem plasmaS Müllertz
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1970
A system for identification and distribution of samples and for processing and storage of data in clinical chemistryS Müllertz
The Biochemical Journal|December 1, 1976
The primary inhibitor of plasmin in human plasmaS Müllertz, I Clemmensen
Biochimica Et Biophysica Acta|January 11, 1977
Kinetic studies of the urokinase catalysed conversion of NH2-terminal lysine plasminogen to plasminU Christensen, S Müllertz
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1974
Rate of activation and electrophoretic mobility of unmodified and partially degraded plasminogen. Effects of 6-aminohexanoic acid and related compoundsS Thorsen, S Müllertz
Ugeskrift for Laeger|January 16, 1978
[Clinical chemistry]O Siggaard-Andersen, S Müllertz
Haemostasis|January 1, 1976
Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasmaI Clemmensen, S Thorsen, S Müllertz
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Biochemical Journal|November 1, 1974
Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrinS Müllertz
Scandinavian Journal of Haematology. Supplementum|January 1, 1979
The fibrinolytic systemS Müllertz
Seminars in Thrombosis and Hemostasis|January 1, 1984
Fibrinolysis: an overviewS Müllertz
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1972
Molecular forms of plasmin and protease inhibitors in human fibrinolytic post-mortem plasmaS Müllertz
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1970
A system for identification and distribution of samples and for processing and storage of data in clinical chemistryS Müllertz
The Biochemical Journal|December 1, 1976
The primary inhibitor of plasmin in human plasmaS Müllertz, I Clemmensen
Biochimica Et Biophysica Acta|January 11, 1977
Kinetic studies of the urokinase catalysed conversion of NH2-terminal lysine plasminogen to plasminU Christensen, S Müllertz
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1974
Rate of activation and electrophoretic mobility of unmodified and partially degraded plasminogen. Effects of 6-aminohexanoic acid and related compoundsS Thorsen, S Müllertz
Ugeskrift for Laeger|January 16, 1978
[Clinical chemistry]O Siggaard-Andersen, S Müllertz
Haemostasis|January 1, 1976
Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasmaI Clemmensen, S Thorsen, S Müllertz
Pageof 2